276 related articles for article (PubMed ID: 16299278)
21. Active and passive immunizations with the streptococcal esterase Sse protect mice against subcutaneous infection with group A streptococci.
Liu M; Zhu H; Zhang J; Lei B
Infect Immun; 2007 Jul; 75(7):3651-7. PubMed ID: 17502395
[TBL] [Abstract][Full Text] [Related]
22. A Multicomponent Vaccine Provides Immunity against Local and Systemic Infections by Group A Streptococcus across Serotypes.
Bi S; Xu M; Zhou Y; Xing X; Shen A; Wang B
mBio; 2019 Nov; 10(6):. PubMed ID: 31772056
[TBL] [Abstract][Full Text] [Related]
23. Immunization with a streptococcal multiple-epitope recombinant protein protects mice against invasive group A streptococcal infection.
Kuo CF; Tsao N; Hsieh IC; Lin YS; Wu JJ; Hung YT
PLoS One; 2017; 12(3):e0174464. PubMed ID: 28355251
[TBL] [Abstract][Full Text] [Related]
24. Local Th17/IgA immunity correlate with protection against intranasal infection with Streptococcus pyogenes.
Mortensen R; Christensen D; Hansen LB; Christensen JP; Andersen P; Dietrich J
PLoS One; 2017; 12(4):e0175707. PubMed ID: 28414746
[TBL] [Abstract][Full Text] [Related]
25. Group A
Wang S; Zhao Y; Wang G; Feng S; Guo Z; Gu G
ACS Infect Dis; 2020 Feb; 6(2):281-290. PubMed ID: 31872763
[TBL] [Abstract][Full Text] [Related]
26. An Experimental Group A
Rivera-Hernandez T; Carnathan DG; Jones S; Cork AJ; Davies MR; Moyle PM; Toth I; Batzloff MR; McCarthy J; Nizet V; Goldblatt D; Silvestri G; Walker MJ
mBio; 2019 Apr; 10(2):. PubMed ID: 31040243
[TBL] [Abstract][Full Text] [Related]
27. Primary induction of CD4 T cell responses in nasal associated lymphoid tissue during group A streptococcal infection.
Park HS; Costalonga M; Reinhardt RL; Dombek PE; Jenkins MK; Cleary PP
Eur J Immunol; 2004 Oct; 34(10):2843-53. PubMed ID: 15368301
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of polymeric encapsulated C5a peptidase-based group B streptococcus vaccines in a murine model.
Santillan DA; Rai KK; Santillan MK; Krishnamachari Y; Salem AK; Hunter SK
Am J Obstet Gynecol; 2011 Sep; 205(3):249.e1-8. PubMed ID: 21802065
[TBL] [Abstract][Full Text] [Related]
29. Nasal associated lymphoid tissue & M cells, a window to persistent streptococcal infections.
Cleary PP; Zhang Y; Park HS
Indian J Med Res; 2004 May; 119 Suppl():57-60. PubMed ID: 15232163
[TBL] [Abstract][Full Text] [Related]
30. Differing Efficacies of Lead Group A Streptococcal Vaccine Candidates and Full-Length M Protein in Cutaneous and Invasive Disease Models.
Rivera-Hernandez T; Pandey M; Henningham A; Cole J; Choudhury B; Cork AJ; Gillen CM; Ghaffar KA; West NP; Silvestri G; Good MF; Moyle PM; Toth I; Nizet V; Batzloff MR; Walker MJ
mBio; 2016 Jun; 7(3):. PubMed ID: 27302756
[TBL] [Abstract][Full Text] [Related]
31. C5a peptidase alters clearance and trafficking of group A streptococci by infected mice.
Ji Y; McLandsborough L; Kondagunta A; Cleary PP
Infect Immun; 1996 Feb; 64(2):503-10. PubMed ID: 8550199
[TBL] [Abstract][Full Text] [Related]
32. Intranasal immunization with multivalent group A streptococcal vaccines protects mice against intranasal challenge infections.
Hall MA; Stroop SD; Hu MC; Walls MA; Reddish MA; Burt DS; Lowell GH; Dale JB
Infect Immun; 2004 May; 72(5):2507-12. PubMed ID: 15102757
[TBL] [Abstract][Full Text] [Related]
33. Clinical and microbiological response of mice to intranasal inoculation with Lactococcus lactis expressing Group A Streptococcus antigens, to be used as an anti-streptococcal vaccine.
García PC; Paillavil BA; Scioscia N; Dale JB; Legarraga P; Salazar-Echegarai FJ; Bueno SM; Kalergis AM; Wozniak A
Microbiol Immunol; 2018 Nov; 62(11):711-719. PubMed ID: 30357922
[TBL] [Abstract][Full Text] [Related]
34. Mucosal vaccine made from live, recombinant Lactococcus lactis protects mice against pharyngeal infection with Streptococcus pyogenes.
Mannam P; Jones KF; Geller BL
Infect Immun; 2004 Jun; 72(6):3444-50. PubMed ID: 15155651
[TBL] [Abstract][Full Text] [Related]
35. Induction of TGF-beta1 and TGF-beta1-dependent predominant Th17 differentiation by group A streptococcal infection.
Wang B; Dileepan T; Briscoe S; Hyland KA; Kang J; Khoruts A; Cleary PP
Proc Natl Acad Sci U S A; 2010 Mar; 107(13):5937-42. PubMed ID: 20231435
[TBL] [Abstract][Full Text] [Related]
36. Group A streptococcus (GAS) carbohydrate as an immunogen for protection against GAS infection.
Sabharwal H; Michon F; Nelson D; Dong W; Fuchs K; Manjarrez RC; Sarkar A; Uitz C; Viteri-Jackson A; Suarez RS; Blake M; Zabriskie JB
J Infect Dis; 2006 Jan; 193(1):129-35. PubMed ID: 16323141
[TBL] [Abstract][Full Text] [Related]
37. Immunization with Staphylococcus aureus clumping factor B, a major determinant in nasal carriage, reduces nasal colonization in a murine model.
Schaffer AC; Solinga RM; Cocchiaro J; Portoles M; Kiser KB; Risley A; Randall SM; Valtulina V; Speziale P; Walsh E; Foster T; Lee JC
Infect Immun; 2006 Apr; 74(4):2145-53. PubMed ID: 16552044
[TBL] [Abstract][Full Text] [Related]
38. Analysis of the coverage capacity of the StreptInCor candidate vaccine against Streptococcus pyogenes.
De Amicis KM; Freschi de Barros S; Alencar RE; Postól E; Martins Cde O; Arcuri HA; Goulart C; Kalil J; Guilherme L
Vaccine; 2014 Jul; 32(32):4104-10. PubMed ID: 23994376
[TBL] [Abstract][Full Text] [Related]
39. Defense from the Group A Streptococcus by active and passive vaccination with the streptococcal hemoprotein receptor.
Huang YS; Fisher M; Nasrawi Z; Eichenbaum Z
J Infect Dis; 2011 Jun; 203(11):1595-601. PubMed ID: 21592989
[TBL] [Abstract][Full Text] [Related]
40. A novel live vector group A streptococcal emm type 9 vaccine delivered intranasally protects mice against challenge infection with emm type 9 group A streptococci.
Wozniak A; García P; Geoffroy EA; Aguirre DB; González SA; Sarno VA; Dale JB; Salazar-Echegarai FJ; Vera A; Bueno SM; Kalergis AM
Clin Vaccine Immunol; 2014 Sep; 21(9):1343-9. PubMed ID: 25056362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
